F-star Therapeutics, Inc. (FSTX) Financials

NASDAQ Currency in USD Disclaimer

$7.12

north_east NA Past Year
Day's range
$7.11
Day's range
$7.12

FSTX Income statement / Annual

Last year (2021), F-star Therapeutics, Inc.'s total revenue was $21.17 M, an increase of 88.05% from the previous year. In 2021, F-star Therapeutics, Inc.'s net income was -$31.28 M. See F-star Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $21.17 M $11.26 M $28.32 M $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $21.17 M $11.26 M $28.32 M $0.00 $0.00 $0.00
Gross Profit Ratio 1 1 1 0 0 0
Research and Development Expenses $28.75 M $14.13 M $31.39 M $19.75 M $13.08 M $14.02 M
General & Administrative Expenses $23.13 M $19.51 M $15.28 M $8.72 M $8.18 M $5.74 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $23.13 M $19.51 M $15.28 M $8.72 M $8.18 M $5.74 M
Other Expenses $651,000.00 -$3.24 M -$1.25 M $0.00 $0.00 $0.00
Operating Expenses $51.88 M $33.64 M $46.67 M $28.47 M $21.25 M $19.76 M
Cost And Expenses $51.88 M $33.64 M $46.67 M $28.47 M $21.25 M $19.76 M
Interest Income $0.00 $0.00 $0.00 $999,000.00 $369,000.00 $96,000.00
Interest Expense $844,000.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $1.29 M $1.14 M $9.15 M $288,000.00 $158,000.00 $118,000.00
EBITDA -$29.42 M -$21.24 M -$13.35 M -$28.47 M -$21.25 M -$19.40 M
EBITDA Ratio -1.39 -1.89 -0.47 0 0 0
Operating Income Ratio -1.45 -1.99 -0.79 0 0 0
Total Other Income/Expenses Net -$941,000.00 -$3.24 M -$1.60 M $5.62 M -$6.43 M $2.04 M
Income Before Tax -$31.66 M -$25.62 M -$23.75 M -$22.85 M -$27.68 M -$17.37 M
Income Before Tax Ratio -1.5 -2.28 -0.84 0 0 0
Income Tax Expense -$372,000.00 -$1,000.00 -$737,000.00 $0.00 $0.00 $0.00
Net Income -$31.28 M -$25.62 M -$23.01 M -$22.85 M -$27.68 M -$17.37 M
Net Income Ratio -1.48 -2.28 -0.81 0 0 0
EPS -1.88 -9.69 -2.54 -0.0016 -0.0025 -0.0024
EPS Diluted -1.88 -9.69 -2.54 -0.0016 -0.0025 -0.0024
Weighted Average Shares Out $16.65 M $2.64 M $9.07 M $14.62 B $11.15 B $7.26 B
Weighted Average Shares Out Diluted $16.65 M $2.64 M $9.07 M $14.62 B $11.15 B $7.26 B
Link